{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:56:52Z","timestamp":1778777812821,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1053\/j.jvca.2025.03.024","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:06:18Z","timestamp":1742198778000},"page":"1774-1781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anesthesia-specific Protocol for Percutaneous Hepatic Perfusion Procedures"],"prefix":"10.1053","volume":"39","author":[{"given":"Daniel A.","family":"Nahrwold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navindra","family":"Doobay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"David A.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Cosnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon K.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.03.024_bib0001","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cncr.28480","article-title":"Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options","volume":"120","author":"Agarwala","year":"2014","journal-title":"Cancer"},{"key":"10.1053\/j.jvca.2025.03.024_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11071007","article-title":"Metastatic uveal melanoma: Treatment strategies and survival-Results from the Dutch Melanoma Treatment Registry","volume":"11","author":"Jochems","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.jvca.2025.03.024_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/CMR.0b013e3283403ce9","article-title":"Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma","volume":"20","author":"Homsi","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1053\/j.jvca.2025.03.024_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1908065","article-title":"Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma","volume":"2018","author":"Mignard","year":"2018","journal-title":"J Oncol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13184726","article-title":"Meta-analysis of isolated hepatic perfusion and percutaneous hepatic perfusion as a treatment for uveal melanoma liver metastases","volume":"13","author":"Bethlehem","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.jvca.2025.03.024_bib0006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.hoc.2024.08.007","article-title":"Hepatic perfusion for diffuse metastatic cancer to the liver: Open and percutaneous techniques","volume":"39","author":"Alexander","year":"2025","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.jvca.2025.03.024_bib0007","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.jvca.2013.07.022","article-title":"Use of partial venovenous cardiopulmonary bypass in percutaneous hepatic perfusion for patients with diffuse, isolated liver metastases: A case series","volume":"28","author":"Fitzpatrick","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2025.03.024_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820983019","article-title":"Over 12 years single institutional experience performing percutaneous hepatic perfusion for unresectable liver metastases","volume":"27","author":"Carr","year":"2020","journal-title":"Cancer Control"},{"key":"10.1053\/j.jvca.2025.03.024_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/cancers14010118","article-title":"Percutaneous hepatic perfusion (PHP) with melphalan in liver-dominant metastatic uveal melanoma: The German experience","volume":"14","author":"Dewald","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.jvca.2025.03.024_bib0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1245\/s10434-015-4968-3","article-title":"Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases","volume":"23","author":"Hughes","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0011","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1213\/XAA.0000000000000496","article-title":"Percutaneous isolated hepatic perfusion: Hemodynamic monitoring and goal-directed anesthetic management: A case Report","volume":"8","author":"Martin-Delgado","year":"2017","journal-title":"A A Case Rep"},{"key":"10.1053\/j.jvca.2025.03.024_bib0012","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jso.23501","article-title":"Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience","volume":"109","author":"Forster","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0013","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00270-015-1276-z","article-title":"Percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies","volume":"39","author":"Burgmans","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0014","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000003981","article-title":"Anticoagulation management and heparin resistance during cardiopulmonary bypass: A survey of Society of Cardiovascular Anesthesiologists Members","volume":"129","author":"Sniecinski","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.03.024_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1213\/ANE.0000000000002613","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical practice guidelines-Anticoagulation during cardiopulmonary bypass","volume":"126","author":"Shore-Lesserson","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2025.03.024_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241246898","article-title":"Troponin elevation in patients undergoing percutaneous hepatic perfusion for metastatic uveal melanoma","volume":"31","author":"Chandrasekhar","year":"2024","journal-title":"Cancer Control"},{"key":"10.1053\/j.jvca.2025.03.024_bib0017","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jtha.2023.04.005","article-title":"What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives","volume":"21","author":"Levy","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2025.03.024_bib0018","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1245\/s10434-024-15293-x","article-title":"Efficacy and safety of the melphalan\/hepatic delivery system in patients with unresectable metastatic uveal melanoma: Results from an open-label, single-arm, multicenter phase 3 study","volume":"31","author":"Zager","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254817","article-title":"Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery","volume":"16","author":"Struck","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2025.03.024_bib0020","unstructured":"Institute for Safe Medicine Practices. Smart infusion pump investigations after an unexplained over-infusion. ISMP Newsletter 2023;28. Retrieved from: https:\/\/www.ismp.org\/sites\/default\/files\/newsletter-issues\/20230518.pdf."},{"key":"10.1053\/j.jvca.2025.03.024_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers16213698","article-title":"Peri-interventional hemodynamic management strategies for percutaneous chemosaturation of the liver in metastatic cancer","volume":"16","author":"Rehn","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.jvca.2025.03.024_bib0022","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/ALN.0000000000003903","article-title":"Anticoagulation monitoring for perioperative physicians","volume":"135","author":"Maier","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2025.03.024_bib0023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CMR.0000000000000947","article-title":"Quality of life after melphalan percutaneous hepatic perfusion for patients with metastatic uveal melanoma","volume":"34","author":"Vigneswaran","year":"2024","journal-title":"Melanoma Res"},{"key":"10.1053\/j.jvca.2025.03.024_bib0024","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00270-024-03713-0","article-title":"Quality of life analysis of patients treated with percutaneous hepatic perfusion for uveal melanoma liver metastases","volume":"47","author":"Tong","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00270-022-03338-1","article-title":"Combining melphalan percutaneous hepatic perfusion with ipilimumab plus nivolumab in advanced uveal melanoma: First safety and efficacy data from the phase Ib part of the Chopin trial","volume":"46","author":"Tong","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0026","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1245\/s10434-024-15364-z","article-title":"ASO author reflections: Percutaneous hepatic perfusion: Past, present, and future","volume":"31","author":"Zager","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.jvca.2025.03.024_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2024.102143","article-title":"Advances in the management of regionally metastatic melanoma","volume":"57","author":"Balsay-Patel","year":"2024","journal-title":"Surg Oncol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025002228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077025002228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T22:06:07Z","timestamp":1750543567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077025002228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1053077025002228"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.03.024","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anesthesia-specific Protocol for Percutaneous Hepatic Perfusion Procedures","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}